New drug tested for severe skin rash and itch
NCT ID NCT06436183
Summary
This study tested a new drug called camoteskimab for adults with moderate to severe eczema (atopic dermatitis). For the first 16 weeks, some participants received the drug and others received a placebo, then everyone received the drug. The main goal was to see if the drug safely reduced the severity and area of the skin rash and improved itching.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Dermatology and Skin Cancer Center - Saint Joseph
Saint Joseph, Missouri, 64506, United States
-
Amicis Research Center (Northridge)
Northridge, California, 91324, United States
-
Avita Clinical Research - Dermatology
Tampa, Florida, 33613, United States
-
California Allergy and Asthma Medical Group
Los Angeles, California, 90025, United States
-
California Dermatology & Clinical Research Institute
Encinitas, California, 92024, United States
-
Center for Clinical Studies
Houston, Texas, 77004, United States
-
Center for Dermatology Clinical Research, Inc.
Fremont, California, 94538, United States
-
Central Sooner Research
Oklahoma City, Oklahoma, 73071, United States
-
Clinical Sciences Institute
Santa Monica, California, 90404, United States
-
Clinical Trial Network
Houston, Texas, 77074, United States
-
Clinique Dermatologique de Sherbrooke
Sherbrooke, Quebec, J1G 1X9, Canada
-
Clinique Medicale Saint-Louis
Québec, Quebec, G1W 4R4, Canada
-
Cura Clinical Research
Oxnard, California, 93030, United States
-
D&H National Research Centers, Inc.
Miami, Florida, 33155, United States
-
Dawes Fretzin Clinical Research
Indianapolis, Indiana, 46250, United States
-
First OC Dermatology Research, Inc.
Fountain Valley, California, 92708, United States
-
Kingsway Clinical Research
Etobicoke, Ontario, M8X 1Y9, Canada
-
M3 Wake Research, Inc.
Raleigh, North Carolina, 27612, United States
-
Medical Dermatology Specialists, PC/US Dermatology Partners
Phoenix, Arizona, 85006, United States
-
Michigan Dermatology Institute
Waterford, Michigan, 28329, United States
-
ObjectiveHealth-The Skin Surgery Center for Clinical Research
Winston-Salem, North Carolina, 27103, United States
-
Owensboro Dermatology Associates
Owensboro, Kentucky, 42303, United States
-
Paddington Testing Co. Inc
Philadelphia, Pennsylvania, 19103, United States
-
Rejuvenation Dermatology Clinic Edmonton South
Edmonton, Alberta, T6W 0J5, Canada
-
Renaissance Research and Medical Group
Cape Coral, Florida, 33991, United States
-
Revival Research Institute
Troy, Michigan, 48084, United States
-
Rodgers Dermatology
Frisco, Texas, 75034, United States
-
Skin Sciences, PLLC
Louisville, Kentucky, 40217, United States
-
Skin Specialists PC
Omaha, Nebraska, 68144, United States
-
Sneeze, Wheeze & Itch Associates, LLC
Normal, Illinois, 61761, United States
-
Somerset Skin Centre
Troy, Michigan, 48084, United States
-
Unity Clinical Research - Dermatology
Oklahoma City, Oklahoma, 73118, United States
-
University of California Los Angeles Dermatology
Los Angeles, California, 90095, United States
-
VASDHS - Veterans Affairs San Diego Medical Center
San Diego, California, 92161, United States
-
Youthful Image
Edmonton, Alberta, T5J 3S9, Canada
Conditions
Explore the condition pages connected to this study.